South Korea
· Delayed Price · Currency is KRW CXI Healthcare Technology Group Statistics
Total Valuation
CXI Healthcare Technology Group has a market cap or net worth of KRW 20.14 billion. The enterprise value is -157.98 billion.
| Market Cap | 20.14B |
| Enterprise Value | -157.98B |
Important Dates
The last earnings date was Friday, November 29, 2024.
| Earnings Date | Nov 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CXI Healthcare Technology Group has 300.58 million shares outstanding. The number of shares has increased by 109.46% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 300.58M |
| Shares Change (YoY) | +109.46% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 29.24% |
| Owned by Institutions (%) | n/a |
| Float | 201.55M |
Valuation Ratios
The trailing PE ratio is 0.65.
| PE Ratio | 0.65 |
| Forward PE | n/a |
| PS Ratio | 0.27 |
| PB Ratio | 0.04 |
| P/TBV Ratio | 0.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.52 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 96.38, with a Debt / Equity ratio of 0.00.
| Current Ratio | 96.38 |
| Quick Ratio | 95.79 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | n/a |
| Interest Coverage | 3,800.76 |
Financial Efficiency
Return on equity (ROE) is 6.26% and return on invested capital (ROIC) is 2.41%.
| Return on Equity (ROE) | 6.26% |
| Return on Assets (ROA) | 2.40% |
| Return on Capital (ROIC) | 2.41% |
| Revenue Per Employee | 6.74B |
| Profits Per Employee | 2.86B |
| Employee Count | 10 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 326.52 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.64% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -39.64% |
| 50-Day Moving Average | 76.24 |
| 200-Day Moving Average | 96.47 |
| Relative Strength Index (RSI) | 40.23 |
| Average Volume (20 Days) | 1,661,599 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CXI Healthcare Technology Group had revenue of KRW 67.42 billion and earned 28.60 billion in profits. Earnings per share was 103.22.
| Revenue | 67.42B |
| Gross Profit | 27.95B |
| Operating Income | 17.63B |
| Pretax Income | 28.59B |
| Net Income | 28.60B |
| EBITDA | 41.87B |
| EBIT | 17.63B |
| Earnings Per Share (EPS) | 103.22 |
Balance Sheet
The company has 178.42 billion in cash and 292.14 million in debt, giving a net cash position of 178.12 billion or 592.60 per share.
| Cash & Cash Equivalents | 178.42B |
| Total Debt | 292.14M |
| Net Cash | 178.12B |
| Net Cash Per Share | 592.60 |
| Equity (Book Value) | 483.05B |
| Book Value Per Share | 1,675.90 |
| Working Capital | 194.89B |
Cash Flow
| Operating Cash Flow | 45.35B |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 41.46%, with operating and profit margins of 26.15% and 42.42%.
| Gross Margin | 41.46% |
| Operating Margin | 26.15% |
| Pretax Margin | 42.41% |
| Profit Margin | 42.42% |
| EBITDA Margin | 62.10% |
| EBIT Margin | 26.15% |
| FCF Margin | n/a |
Dividends & Yields
CXI Healthcare Technology Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -109.46% |
| Shareholder Yield | -109.46% |
| Earnings Yield | 154.05% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 29, 2016. It was a forward split with a ratio of 1.05.
| Last Split Date | Jun 29, 2016 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
CXI Healthcare Technology Group has an Altman Z-Score of 9.06.
| Altman Z-Score | 9.06 |
| Piotroski F-Score | n/a |